Monday, July 23, 2012

Localized Prostate Cancer: Removal No Better Than Observation ...

Featured Article
Academic Journal
Main Category: Prostate / Prostate Cancer
Also Included In: Urology / Nephrology;??Men?s Health
Article Date: 23 Jul 2012 ? 3:00 PDT

email to a friend ? printer friendly ? opinions ?

<!? rate article


Advertisement

Patient / Public:

Healthcare Prof:

4 (1 votes)

A large study that followed men across the US diagnosed with localized prostate cancer for over 10 years found they lived just as long whether they
had surgery to remove the prostate or underwent observation. The researchers say their findings support observation over surgery for men with localized
prostate cancer, especially if it is low-risk.

In their study, which was published online on 19 July in the New England Journal of Medicine, researchers from the Prostate Cancer Intervention versus
Observation Trial (PIVOT) describe how, following diagnosis, between November 1994 through January 2002, they enrolled 731 men with localized prostate
cancer, randomly assigned them to receive either radical prostatectomy or observation, and then followed their progress.

Radical prostatectomy is a surgical procedure that removes the entire prostate gland and some surrounding tissue.

The Study: Surgery Versus Observation

The average age of the men at diagnosis was 67 years, and the method of diagnosis was through prostate specific antigen (PSA) blood tests and biopsies. About
half the men went into the surgery group (364), and half into the observation group (367).

Although the observation group did not have the surgery, they were able to receive palliative care and chemotherapy if their cancer got worse.

During the median follow-up of 10 years, 47% (171 men) in the surgery group died, compared with 49.9% (183) in the observation group. In their analysis, the
researchers calculated the hazard ratio for this as 0.88, with confidence interval (CI) ranging from 0.71 to 1.08 (P=0.22), and an absolute risk reduction of 2.9
percentage points.

In the surgery group, 5.8% of the men (21) died from prostate cancer or treatment, compared with 8.4% (31) in the observation group. For this, the calculated
hazard ratio was 0.63, with 95% CI ranging from 0.36 to 1.09 (P=0.09) and an absolute risk reduction of 2.6 percentage points.

These figures did not change when they took into account other potential influencing factors such as age, race, medical conditions, and the type of
tumor.

21.4% of the men in the surgery group had a complication within the first 30 days, the most common being infection. One of the men also died during this
period.

Two years after surgery, urinary incontinence and impotence (erectile dysfunction) were much more common among the men in the surgery group than in the
observation group.

Observation Better Option for Low Risk Categories

The researchers classified the men, according to their PSA levels and Gleason scores, as having either low, intermediate, or high-risk prostate cancer.

The results showed that the men with low-risk cancer (PSA under 10, Gleason score under 7), were the least likely to benefit from radical
prostatectomy
.

The researchers say their findings support the idea that if the cancer is low risk, then observation is a better option for men with localized prostate
cancer
.

?Active Surveillance? Has Overtaken ?Watchful Waiting?

Although prostate cancer is a serious disease, and statistics show that it is the leading cause of cancer death among American men, most men diagnosed with the disease die with it rather than of it. In fact, more than 2.5 million men in the US who have been diagnosed with prostate cancer are alive today.

One of the problems with prostate cancer screening is that it can?t tell which cancers are aggressive and need treatment and which can be safely left alone and
kept under observation. So, because of this, many men undergo surgery, which can often lead to unpleasant and sometimes long-lasting side effects such as
impotence and incontinence.

However, the American Cancer Society says much has happened over the last few years to improve the treatment of prostate
cancer patients.

?Watchful waiting?, until recently, was widely used. This meant waiting until the cancer caused symptoms before starting treatment.

But now, the more common approach is ?active surveillance? or ?expectant management?, which involves regular PSA tests, rectal exams and biopsies to more
closely assess the level of threat, and if this rises, then the doctor may recomment radical treatment.

Men Should Understand Benefits Versus Risks of Screening

Men with average risk of prostate cancer should talk to their doctors about screening from the age of 50 onwards, says the American Cancer Society. For men at
higher risk, including those with a father or brother who has prostate cancer, and African-American men, should have this conversation from the age of 45, they
urge.

In a recent statement, the American Society of Clinical Oncology (ASCO) suggests for men
with shorter life expectancy, the risks of harms from PSA tests and subsquent unnecessary treatment probably outweigh the benefits.

But for men with longer life expectancy, the risk versus benefit balance is less clear, and patients should have ?well-informed? conversations with their doctors
about the harms, potential benefits and the appropriate management options should prostate cancer be found, says the ASCO.

Written by Catharine Paddock PhD

Copyright: Medical News Today

Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

?Localized Prostate Cancer: Removal No Better Than Observation, Study?

Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

Privacy Policy |
Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd ? 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

back to top | home |
privacy policy

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd ? 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Article source: http://www.medicalnewstoday.com/articles/248143.php

Source: http://cancerkick.com/2012/07/23/localized-prostate-cancer-removal-no-better-than-observation-study/

breitbart dead db cooper fafsa branson missouri davy jones dead monkees last train to clarksville

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.